<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fung SY</submitter><funding>NHGRI NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>CIHR</funding><pagination>247-57</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4371607</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Toll-like receptors (TLRs) play a critical role in innate immunity, but activation of TLR signaling pathways is also associated with many harmful inflammatory diseases. Identification of novel anti-inflammatory molecules targeting TLR signaling pathways is central to the development of new treatment approaches for acute and chronic inflammation. We performed high-throughput screening from crude marine sponge extracts on TLR5 signaling and identified girolline. We demonstrated that girolline inhibits signaling through both MyD88-dependent and -independent TLRs (i.e., TLR2, 3, 4, 5, and 7) and reduces cytokine (IL-6 and IL-8) production in human peripheral blood mononuclear cells and macrophages. Using a chemical genomics approach, we identified Elongation Factor 2 as the molecular target of</pubmed_abstract><journal>ACS chemical biology</journal><pubmed_title>Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.</pubmed_title><pmcid>PMC4371607</pmcid><funding_grant_id>1R01HG005084-01A1</funding_grant_id><funding_grant_id>MOP-57830</funding_grant_id><funding_grant_id>R01 GM104975</funding_grant_id><funding_grant_id>R01 HG005084</funding_grant_id><funding_grant_id>1R01GM104975-01</funding_grant_id><pubmed_authors>Woods K</pubmed_authors><pubmed_authors>Fung SY</pubmed_authors><pubmed_authors>Piotrowski JS</pubmed_authors><pubmed_authors>Victor RE</pubmed_authors><pubmed_authors>Boone C</pubmed_authors><pubmed_authors>Li SC</pubmed_authors><pubmed_authors>Myers CL</pubmed_authors><pubmed_authors>de Voogd NJ</pubmed_authors><pubmed_authors>Sofiyev V</pubmed_authors><pubmed_authors>Deshpande R</pubmed_authors><pubmed_authors>Hirschfeld AF</pubmed_authors><pubmed_authors>Andersen RJ</pubmed_authors><pubmed_authors>Schneiderman J</pubmed_authors><pubmed_authors>Turvey SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.</name><description>Toll-like receptors (TLRs) play a critical role in innate immunity, but activation of TLR signaling pathways is also associated with many harmful inflammatory diseases. Identification of novel anti-inflammatory molecules targeting TLR signaling pathways is central to the development of new treatment approaches for acute and chronic inflammation. We performed high-throughput screening from crude marine sponge extracts on TLR5 signaling and identified girolline. We demonstrated that girolline inhibits signaling through both MyD88-dependent and -independent TLRs (i.e., TLR2, 3, 4, 5, and 7) and reduces cytokine (IL-6 and IL-8) production in human peripheral blood mononuclear cells and macrophages. Using a chemical genomics approach, we identified Elongation Factor 2 as the molecular target of</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jan</publication><modification>2025-04-18T19:18:19.691Z</modification><creation>2019-03-27T01:48:41Z</creation></dates><accession>S-EPMC4371607</accession><cross_references><pubmed>24117378</pubmed><doi>10.1021/cb400740c</doi></cross_references></HashMap>